Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

CpG Methylation Signature Predicts Recurrence in Early-Stage Hepatocellular Carcinoma: Results From a Multicenter Study

23 Feb 2017

Abstract excerpt

Purpose Early-stage hepatocellular carcinoma (E-HCC) is being diagnosed increasingly, and in one half of diagnosed patients, recurrence will develop. Thus, it is urgent to identify recurrence-related markers. We investigated the effectiveness of CpG methylation in predicting recurrence for patients with E-HCCs. Patients and Methods In total, 576 patients with E-HCC from four independent centers were sorted by...

Topics

Join the communities discussing this publication.

Cancer-related molecular mechanisms research
Epigenetics and DNA Methylation
Liver Disease Diagnosis and Treatment

Source

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Identifiers

PMID: 28068175
DOI: 10.1200/jco.2016.68.2153

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 1 Sept 2026.

Community interpretation

Discuss the evidence

Ask a question, add context or challenge an interpretation. Community activity is separate from scientific evidence strength.

0

discussions

0

replies

Citations encouraged

Claims remain attributable.

No discussion yet

Be the first to add a careful, cited interpretation.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

CpG Methylation Signature Predicts Recurrence in Early-Stage Hepatocellular Carcinoma: Results From a Multicenter StudyPMID 28068175Read ↗

Identification of a novel gene signature for the prediction of recurrence in HCC patients by machine learning of genome-wide databasesSemantic proximity Read ↗

DNA methylation-driven genes for constructing diagnostic, prognostic, and recurrence models for hepatocellular carcinomaSemantic proximity Read ↗

Integrative multi-omics approach for stratification of tumor recurrence risk groups of Hepatocellular Carcinoma patientsSemantic proximity Read ↗

Classification of early and late stage liver hepatocellular carcinoma patients from their genomics and epigenomics profilesSemantic proximity Read ↗

Combining a machine-learning derived 4-lncRNA signature with AFP and TNM stages in predicting early recurrence of hepatocellular carcinomaSemantic proximity Read ↗

Predicting overall survival of patients with hepatocellular carcinoma using a three‐category method based on DNA methylation and machine learningSemantic proximity Read ↗

ABCB6 mRNA and DNA methylation levels serve as useful biomarkers for prediction of early intrahepatic recurrence of hepatitis C virus-related hepatocellular carcinomaSemantic proximity Read ↗

A CpGs Methylation Signature as Potential Marker for Early Diagnosis of Hepatocellular Carcinoma from HBV-Related Liver Disease using Multiplex Bisulfite SequencingSemantic proximity Read ↗

Immune-Related DNA Methylation Data-Based Molecular Classification Associated with the Prognosis of Patients with Hepatocellular CarcinomaSemantic proximity Read ↗

Comprehensive Molecular Analyses of a Six-Gene Signature for Predicting Late Recurrence of Hepatocellular CarcinomaSemantic proximity Read ↗

Hepatocellular Carcinoma Displays Distinct DNA Methylation Signatures with Potential as Clinical PredictorsSemantic proximity Read ↗

DNA methylation profile in CpG-depleted regions uncovers a high-risk subtype of early-stage colorectal cancerSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.